Elon Musk Claims His New Startup Neuralink Is Ready to Install First Neural Chips in 2020
Brain-computer startup Neuralink is going to have its first human patient by the end of 2020, the company's founder Elon Musk said during the launch event in San Francisco on Tuesday, July 16.
The startup is now seeking U.S. Food and Drug Administration license to start performing surgeries on humans. Bloomberg reported that the first person will be equipped with an innovative chip by the end of 2020.
Neuralink’s technology implies drilling micro holes into the brain to embed threads connected to a small processor, which, in its turn, will be linked to a smartphone via Bluetooth. According to Musk, there will be an app store where users could purchase different programs working with Neuralink chips.
In 2018, Neuralink conducted animal tests of its technology on rats. The New York Times reportedly saw the footage of a computer receiving information from a chip in rat’s brain. Musk also revealed that Neuralink tested the technology on monkeys. “A monkey has been able to control the computer with his brain,” he told reporters.
Neuralink was first announced by Elon Musk in 2017. Initially, he claimed that the startup would merge the human brain with AI and help people with brain disorders, such as Parkinson and epilepsy. The company is Musk’s fourth major project in a decade.
Musk invested $100 million in Neuralink as a co-founder.
Tokenised securities are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how tokenised securities and leverage work and whether you can afford to take the high risk of losing your money. Nothing in the above article should be regarded as a recommendation to trade generally, to trade on a particular platform or to trade in a particular asset. Asset prices can go down as well as up and past performance is not a guide to future performance. Investors and traders should thoroughly research an asset or strategy before making any trading or investment decision and if necessary seek professional advice.